For low-risk patients on warfarin undergoing surgery, what is the recommended perioperative plan?

For low-risk patients on warfarin undergoing surgery, what is the recommended perioperative plan?

• A. Continue warfarin through the perioperative period
• B. Discontinue warfarin 5 days before and restart 12-24 hours postoperatively
• C. Discontinue warfarin 2 days before and never restart
• D. Bridge with low-molecular-weight heparin

Answer: (B)

Managing warfarin around surgery focuses on balancing bleeding risk with the chance of clotting. Warfarin has a long duration of action, so to reduce intraoperative bleeding you stop it several days before procedures and allow the INR to fall to safer levels. For a patient at low thromboembolic risk, the recommended plan is to discontinue warfarin about five days before surgery and then restart it 12–24 hours after the operation once there is adequate hemostasis. Bridging with low-molecular-weight heparin is not needed in this setting because it increases bleeding risk and adds complexity without improving outcomes for low-risk patients. It’s reserved for those with higher thromboembolic risk where stopping warfarin poses a significant danger.

Managing warfarin around surgery focuses on balancing bleeding risk with the chance of clotting. Warfarin has a long duration of action, so to reduce intraoperative bleeding you stop it several days before procedures and allow the INR to fall to safer levels. For a patient at low thromboembolic risk, the recommended plan is to discontinue warfarin about five days before surgery and then restart it 12–24 hours after the operation once there is adequate hemostasis.

Bridging with low-molecular-weight heparin is not needed in this setting because it increases bleeding risk and adds complexity without improving outcomes for low-risk patients. It’s reserved for those with higher thromboembolic risk where stopping warfarin poses a significant danger.